“Prevalence of Cutaneous Adverse Drug Reactions According to Iraqi Pharmacovigilance Center; A retrospective study for 11 years (2010-2021) ”, AJPS, vol. 24, no. 3, pp. 284–292, Jul. 2024, doi: 10.32947/ajps.v24i3.1070.